Catabasis Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

You can watch CATB and buy or sell other stocks, options, and ETFs commission-free!

About CATB

Catabasis Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of novel therapeutics. Its lead product candidate is edasalonexent, which is intended for the treatment of Duchenne muscular dystrophy. 

CEO
Jill C. Milne
CEOJill C. Milne
Employees
20
Employees20
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2008
Founded2008
Employees
20
Employees20

CATB Key Statistics

Market cap
667.25M
Market cap667.25M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
508.70K
Average volume508.70K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$8.59
52 Week high$8.59
52 Week low
$1.20
52 Week low$1.20

CATB Earnings

-$0.89
-$0.59
-$0.30
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
per share
Estimated per share
Actual
Expected Nov 11, After Hours
ActualExpected Nov 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.